This trial studies selinexor to learn if it can help to shrink tumors in young patients with solid tumors or CNS tumors.
7 Primary · 5 Secondary · Reporting Duration: Up to 2 years
Experimental Treatment
68 Total Participants · 1 Treatment Group
Primary Treatment: Pharmacological Study · No Placebo Group · Phase 1
Age 12 - 21 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 100.0% |
65+ | 100.0% |
UCSF Medical Center-Mission Bay | 100.0% |
Met criteria | 100.0% |